Koda Pharmaceutical

Koda Pharmaceuticals is a specialty pharmaceutical company based in Hørsholm, Denmark, that focuses on the commercialization and distribution of niche medicines within the Nordic region. The company serves as a strategic partner for international pharmaceutical and biotech firms, providing expertise in market access, regulatory affairs, and sales across Denmark, Norway, Sweden, Finland, and Iceland. Koda Pharmaceuticals specializes in therapeutic areas such as addiction medicine, emergency care, and specialized hospital treatments. Their portfolio includes critical products like Nyxoid (intranasal naloxone) for the treatment of opioid overdose, reflecting their commitment to addressing unmet medical needs in specialty care.